What are the indications for mitral valve repair in patients with mitral regurgitation?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Indications for Mitral Valve Repair in Mitral Regurgitation

Mitral valve repair is strongly indicated for symptomatic patients with severe primary mitral regurgitation and preserved left ventricular function (LVEF >30%), and for asymptomatic patients with severe primary mitral regurgitation who have developed left ventricular dysfunction (LVEF ≤60% and/or LVESD ≥40 mm). 1

Primary Mitral Regurgitation Indications

Symptomatic Patients

  • Mitral valve repair for patients with severe primary MR who are symptomatic (NYHA class II-IV) with preserved LV function (LVEF >30%) (Class I recommendation) 1
  • Surgery may be considered in symptomatic patients with severe primary MR and severe LV dysfunction (LVEF ≤30%) (Class IIb recommendation) 1

Asymptomatic Patients

  • Mitral valve repair for asymptomatic patients with severe primary MR and LV dysfunction (LVEF ≤60% and/or LVESD ≥40 mm) (Class I recommendation) 1
  • Mitral valve repair is reasonable in asymptomatic patients with severe primary MR and preserved LV function (LVEF >60% and LVESD <40 mm) when:
    • There is >95% likelihood of successful repair with <1% mortality at a Heart Valve Center of Excellence (Class IIa) 1
    • New onset of atrial fibrillation has occurred (Class IIa) 1
    • Pulmonary hypertension is present (pulmonary artery systolic pressure >50 mmHg at rest) (Class IIa) 1
    • Significant left atrial dilation is present (LA volume index ≥60 mL/m² or diameter >55 mm) (Class IIa) 1

Progressive Disease

  • Mitral valve repair may be considered when there is progressive increase in LV size or decrease in EF on ≥3 serial imaging studies (Class IIb) 1

Secondary Mitral Regurgitation Indications

  • Mitral valve surgery is reasonable for patients with chronic severe secondary MR who are undergoing CABG or AVR (Class IIa) 1
  • For severe ischemic MR in severely symptomatic patients (NYHA III-IV) with persistent symptoms despite optimal GDMT:
    • Chordal-sparing MVR is reasonable over annuloplasty repair (Class IIa) 1
    • MV surgery may be considered for patients with LVEF >30% (Class IIb) 1

Concomitant Surgery Indications

  • Mitral valve repair or replacement is indicated in patients with chronic severe primary MR undergoing cardiac surgery for other indications (Class I) 1
  • Mitral valve repair is reasonable in patients with chronic moderate primary MR (stage B) when undergoing cardiac surgery for other indications (Class IIa) 1

Repair vs. Replacement Considerations

  • Mitral valve repair is strongly preferred over replacement when:
    • Pathology is limited to the posterior leaflet (Class I) 1
    • Anterior leaflet or bileaflet involvement if a successful and durable repair can be accomplished (Class I) 1
  • In secondary MR, chordal-sparing MVR may be preferred over repair in severely symptomatic patients with chronic severe ischemic MR due to lower rates of MR recurrence 1

Timing Considerations

Early surgery should be considered before irreversible LV damage occurs. The most recent evidence suggests that surgery should be encouraged before:

  • LVEF falls below 65%
  • Left atrial volume index reaches 53 mL/m² or more 2

Procedural Success Factors

  • Repair rates approaching 100% are achievable at specialized centers for degenerative mitral valve disease 3
  • Favorable anatomic factors for successful repair include:
    • Longer chordal length (>29 mm)
    • Longer posterior leaflet length (>17 mm)
    • Mitral annulus size >35 mm 4
  • Unfavorable factors include anterior mitral annular calcification 4

Caveats and Pitfalls

  • Waiting for symptoms to develop before referring for surgery may result in irreversible LV damage
  • Repair of severely regurgitant valves should be performed at centers with high repair rates (>90%) and low operative mortality (<1%)
  • Careful echocardiographic assessment is crucial to determine suitability for repair
  • For secondary MR, addressing the underlying ventricular dysfunction is essential, as repair alone may have high failure rates 5
  • Transcatheter mitral valve repair may be considered for severely symptomatic patients with prohibitive surgical risk 1

Mitral valve repair remains the gold standard treatment for primary MR with superior outcomes compared to replacement, preserving LV function and decreasing risks of thromboembolism and anticoagulation-related complications 6.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Identifying patients with degenerative mitral regurgitation for mitral valve repair and replacement: a transesophageal echocardiographic study.

Journal of the American Society of Echocardiography : official publication of the American Society of Echocardiography, 2004

Research

Mitral Valve Surgery for Congestive Heart Failure.

Heart failure clinics, 2018

Research

Mitral valve repair in the treatment of mitral regurgitation.

Current treatment options in cardiovascular medicine, 2009

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.